Results 121 to 130 of about 80,513 (156)

Complement Inhibition for Acute Neuromyelitis Optica Spectrum Disorder Attacks: Insights From an International Case Series. [PDF]

Neurol Neuroimmunol Neuroinflamm
Rommer PS, Jiang W, Nolte JP, Mikami T, De Seze J, Sánchez P, Harel A, Alkabie S, Kaneko K, Bilodeau PA, Misu T, Kremer L, Bigaut K, Leypoldt F, Aktas O, Ringelstein M, Siffrin V, Zhang LJ, Cong H, Lowe M, Barreras P, Chen H, Piquet AL, Sotirchos ES, Kammeyer R, Zook J, Bennett JL, Berger T, Fujihara K, Levy M, Shi FD, Paul F.   +31 more
europepmc   +1 more source

Spatial heterogeneity in microglia-complement crosstalk: Implications for synaptic pruning in Alzheimer's disease. [PDF]

Alzheimers Dement
Ye Q, Gao W, Feng J, Li X, Li J, Yang F, Li L, Zi M, Wu X, Gao H, Li H.   +10 more
europepmc   +1 more source

Redox Regulation of Complement Pathway Activation in Aging and Related Diseases. [PDF]

Antioxidants (Basel)
Ferdowsi S, Arjuna S, Sj S, Zennadi R.
europepmc   +1 more source

The Role of Complement Activation in Diabetic Nephropathy: Current Insights and Future Directions. [PDF]

J Clin Med
Kotsalas N, Fouza A, Daoudaki M.
europepmc   +1 more source

Advances in Complement Inhibition Therapies for Paroxysmal Nocturnal Hemoglobinuria and Autoimmune Hemolytic Disorders. [PDF]

J Blood Med
Tamdin T, Rodgers GM.
europepmc   +1 more source

Current status and challenges of biologic targeted therapy for myasthenia gravis in China. [PDF]

Intractable Rare Dis Res
Gu S, Zhao C.
europepmc   +1 more source

The resistance to Toxoplasma gondii in Microtus fortis is associated with the activation of the complement lectin pathway. [PDF]

PLoS Negl Trop Dis
Xie J, Wu M, Zhou Z, Liu Y, Liu X, Wu K, Yang D, Wang Y, Liu K, Ngim C, Wang Z, Jiang L.   +11 more
europepmc   +1 more source

ECMO-associated nosocomial infections in adults: immunopathogenesis and predictive modeling approaches. [PDF]

Front Med (Lausanne)
Jiang J, Jiang Y, Xu Y, Zhang S.
europepmc   +1 more source

The contribution of the membrane-bound complement regulatory proteins CD46 and CD55 in phases of acute lymphocytic leukemia and acute myelogenous leukemia. [PDF]

Sci Rep
Onsi LA, Ammar P, Abdelaziz H, Abou-Aisha K, Farag N, El-Azizi M.   +5 more
europepmc   +1 more source